We are live on ! Find out more
CAM

Congress Asset Management Portfolio holdings

AUM $16.3B
1-Year Est. Return 42.69%
This Fund
S&P 500
This Quarter Est. Return
+12.32%
1 Year Est. Return
+42.69%
3 Year Est. Return
+133.81%
5 Year Est. Return
+171.24%
10 Year Est. Return
+841.07%
AUM
$9.24B
AUM Growth
+$821M
Cap. Flow
-$67.7M
Cap. Flow %
-0.73%
Top 10 Hldgs %
17.67%
Holding
344
New
21
Increased
124
Reduced
144
Closed
10

Top Sells

Rank Stock Value
1
AVY icon
Avery Dennison
AVY
+$90.1M
2
CTAS icon
Cintas
CTAS
+$88.2M
3
TJX icon
TJX Companies
TJX
+$66.8M
4
CME icon
CME Group
CME
+$57.2M
5
VAR
Varian Medical Systems, Inc.
VAR
+$52M

Sector Composition

Rank Sector Weight
1 Technology 27.98%
2 Healthcare 19.02%
3 Industrials 16.42%
4 Consumer Discretionary 9.17%
5 Consumer Staples 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
126
Ametek
AME
$57.6B
$8.17M 0.09%
82,155
+6,030
+8% +$583K
TREX icon
127
Trex
TREX
$4.93B
$8.13M 0.09%
113,572
+18,390
+19% +$1.27M
HEI icon
128
HEICO Corp
HEI
$50.8B
$8.11M 0.09%
77,469
+9,130
+13% +$943K
SMPL icon
129
Simply Good Foods
SMPL
$988M
$8.09M 0.09%
367,010
+328
+0.1% +$7.62K
EQIX icon
130
Equinix
EQIX
$104B
$8.04M 0.09%
10,576
-391
-4% -$296K
TEL icon
131
TE Connectivity
TEL
$62.3B
$8.03M 0.09%
82,178
+1,385
+2% +$127K
DXCM icon
132
DexCom
DXCM
$31.3B
$7.93M 0.09%
76,912
-14,948
-16% -$1.56M
ILMN icon
133
Illumina
ILMN
$29.3B
$7.9M 0.09%
26,290
-269
-1% -$92.7K
ALXN
134
DELISTED
Alexion Pharmaceuticals
ALXN
$7.81M 0.08%
68,231
+16,478
+32% +$1.78M
ABBV icon
135
AbbVie
ABBV
$431B
$7.75M 0.08%
88,531
+3,075
+4% +$290K
AVGO icon
136
Broadcom
AVGO
$2T
$7.72M 0.08%
212,030
-340
-0.2% -$11.4K
CSCO icon
137
Cisco
CSCO
$476B
$7.61M 0.08%
193,230
+3,750
+2% +$163K
TREE icon
138
LendingTree
TREE
$447M
$7.6M 0.08%
24,779
+4,653
+23% +$1.48M
HELE icon
139
Helen of Troy
HELE
$671M
$7.6M 0.08%
39,290
-1,466
-4% -$291K
BDX icon
140
Becton Dickinson
BDX
$48.8B
$7.56M 0.08%
33,322
+447
+1% +$110K
HUBB icon
141
Hubbell
HUBB
$26.8B
$7.26M 0.08%
53,044
-73
-0.1% -$10.1K
RCM
142
DELISTED
R1 RCM Inc. Common Stock
RCM
$7.21M 0.08%
420,608
-1,756
-0.4% -$25.6K
MEDP icon
143
Medpace
MEDP
$16.3B
$6.98M 0.08%
62,432
-948
-1% -$110K
PEN icon
144
Penumbra
PEN
$12.8B
$6.91M 0.07%
35,559
-1,031
-3% -$217K
URI icon
145
United Rentals
URI
$72.4B
$6.73M 0.07%
38,582
-731
-2% -$123K
CHDN icon
146
Churchill Downs
CHDN
$6.06B
$6.54M 0.07%
79,796
-1,722
-2% -$134K
WNS
147
DELISTED
WNS Holdings
WNS
$6.44M 0.07%
100,621
-23,072
-19% -$1.45M
MSA icon
148
Mine Safety
MSA
$7.48B
$6.17M 0.07%
45,946
+1,310
+3% +$160K
CYBR
149
DELISTED
CyberArk
CYBR
$6.11M 0.07%
59,057
+822
+1% +$88.5K
SAIA icon
150
Saia
SAIA
$9.65B
$6.07M 0.07%
48,081
+402
+0.8% +$51.3K

Similar funds

Congress Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Congress Asset Management held 344 positions worth $9.24B, up 9.8% from $8.41B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Congress Asset Management's Q3 2020 filing shows 21 new, 124 increased, 144 reduced and 10 closed positions. Its largest new stake was Neurocrine Biosciences: 767,650 shares worth $73.8M. The largest sale was Avery Dennison, an estimated $90.1M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Congress Asset Management's largest Q3 2020 buy was Neurocrine Biosciences: 767,650 shares worth $73.8M.
  • Congress Asset Management added most to Caterpillar in Q3 2020, an estimated $70.3M increase.
  • Congress Asset Management's biggest Q3 2020 reduction was Avery Dennison, cutting an estimated $90.1M.
  • Congress Asset Management fully exited QuidelOrtho in Q3 2020, selling an estimated $7.04M.
  • Congress Asset Management's ten largest holdings make up 18% of its $9.24B portfolio in Q3 2020.
  • Congress Asset Management opened 21 new positions and closed 10 in Q3 2020.
  • Congress Asset Management's portfolio value rose 9.8% quarter-over-quarter to $9.24B.

Based on Congress Asset Management's 13F filing for Q3 2020, filed 3 Nov 2020.